U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9678196781Atrial Fibrillation Ablation The Hybrid Approach Versus Traditional ManagementWithdrawnNo Results AvailableAblation of Atrial FibrillationProcedure: Pulmonary vein isolation ablation procedure for atrial fibrillation|Procedure: Hybrid procedure for ablation of atrial fibrillation|Procedure: The Cox Maze Procedure for Ablation of Atrial Fibrillation|Procedure: Hybrid Procedure for Left Atrium >5 cm but - https://ClinicalTrials.gov/show/NCT01298986
9678296782Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract IncisionsCompletedNo Results AvailableCataractsDrug: Viscoat|Drug: Salinehttps://ClinicalTrials.gov/show/NCT01298973
9678396783Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder PatientsSuspendedNo Results AvailableComplications; Artificial Fertilization, Introduction of Embryo in Embryo TransferDrug: Somatropinhttps://ClinicalTrials.gov/show/NCT01298960
9678496784Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal ObstructionsEnrolling by invitationNo Results AvailableRestenosisDevice: Laser Atherectomy (Spectranetics CE marked peripheral laser atherectomy catheters (including Turbo Elite®), Turbo-Booster® and Turbo Tandem™ Systemshttps://ClinicalTrials.gov/show/NCT01298947
9678596785LBH589 (Panobinostat) for the Treatment of MyelofibrosisActive, not recruitingNo Results AvailablePrimary Myelofibrosis|Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase|Post-Essential Thrombocythemia Related MyelofibrosisDrug: LBH589https://ClinicalTrials.gov/show/NCT01298934
9678696786A Pilot Study of Demand Valve Oxygen Inhalation Therapy for Cluster HeadacheRecruitingNo Results AvailableCluster HeadacheDrug: Oxygen|Drug: Oxygenhttps://ClinicalTrials.gov/show/NCT01298921
9678796787Comparison of Treatments in Venous InsufficiencyActive, not recruitingNo Results AvailableVenous InsufficiencyProcedure: Operative treatment|Procedure: Laser ablation|Procedure: Foam sclerotherapyhttps://ClinicalTrials.gov/show/NCT01298908
9678896788Optical Low Coherence Reflectometry Enables Preoperative Detection of Zonular Weakness in Pseudoexfoliation SyndromeCompletedNo Results AvailablePseudoexfoliation Syndromehttps://ClinicalTrials.gov/show/NCT01298895
9678996789Diacerein on Insulin Secretion in DiabetesCompletedNo Results AvailableType 2 Diabetes Mellitus|Overweight|ObesityDrug: Diacerein|Other: Placebohttps://ClinicalTrials.gov/show/NCT01298882
9679096790The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) PatientsRecruitingNo Results AvailableChronic Kidney Disease, Stage IV (Severe)|Chronic Kidney Disease, Stage VBiological: HPV-6/11/16/18 vaccinehttps://ClinicalTrials.gov/show/NCT01298869
9679196791The Effect of Hydrotherapy and Land-based Rehabilitation Program Combined With Ankle Taping in Athletes With Chronic Ankle InstabilityCompletedNo Results AvailableSports Rehabilitation Program|Hydrotherapy|Ankle InstabilityProcedure: hydrotherapyhttps://ClinicalTrials.gov/show/NCT01298856
9679296792Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the HospitalCompletedNo Results AvailableInfectionsDrug: Ceftaroline fosamilhttps://ClinicalTrials.gov/show/NCT01298843
9679396793GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral HemorrhageTerminatedNo Results AvailableIntracerebral Hemorrhage (ICH)Drug: GLP-1 CellBeadshttps://ClinicalTrials.gov/show/NCT01298830
9679496794Use of a Soy-based Meal Replacement Weight Loss Intervention to Impact Ectopic FatCompletedNo Results AvailableAbdominal ObesityDietary Supplement: Medifast meal replacement products|Dietary Supplement: Medifast meal replacement productshttps://ClinicalTrials.gov/show/NCT01298817
9679596795Preventing Maternal Depression In Head StartRecruitingNo Results AvailableDepressionBehavioral: Problem Solving Education and Activated Referral to Carehttps://ClinicalTrials.gov/show/NCT01298804
9679696796The Impact Of Physician Communication On Family Inpatient ExperienceRecruitingNo Results AvailableParental/Patient SatisfactionBehavioral: Sitting|Behavioral: Standinghttps://ClinicalTrials.gov/show/NCT01298791
9679796797High Pain Intervention in Cesarean SectionsCompletedNo Results AvailableOther Chronic Postoperative PainDrug: Duramorph|Drug: Acetaminophenhttps://ClinicalTrials.gov/show/NCT01298778
9679896798Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic PainCompletedNo Results AvailablePain|Low Back Pain|Osteoarthritis|Neuropathic PainDrug: BEMA Buprenorphinehttps://ClinicalTrials.gov/show/NCT01298765
9679996799Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract SurgeryTerminatedNo Results AvailableInflammation|Pain|CataractDrug: Mapracorat|Drug: Vehiclehttps://ClinicalTrials.gov/show/NCT01298752
9680096800Asthma Control Study 2011CompletedNo Results AvailableAsthma Control Levelhttps://ClinicalTrials.gov/show/NCT01298739
9680196801Pharmaceutical Care in Type 2 DiabetesCompletedNo Results AvailableDIABETES MELLITUS, TYPE 2Other: PHARMACEUTICAL CARE|Other: HEALTH USUAL CAREhttps://ClinicalTrials.gov/show/NCT01298726
9680296802Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic CancerActive, not recruitingNo Results AvailableBreast Neoplasms|mTor ProteinDrug: Tamoxifen|Drug: Everolimushttps://ClinicalTrials.gov/show/NCT01298713
9680396803Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionActive, not recruitingNo Results AvailableGlaucoma|Ocular HypertensionDrug: bimatoprost 0.01% ophthalmic solution|Drug: bimatoprost 0.03% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT01298700
9680496804Divided Dose of TRAVATAN®CompletedNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: Travoprost Ophthalmic Solution, 0.00013%|Drug: Travoprost Ophthalmic Solution, 0.00033%|Drug: Travoprost Ophthalmic Solution, 0.001%|Drug: Travoprost Ophthalmic Solution, 0.00267%|Drug: Travoprost Ophthalmic Solution, 0.004%|Drug: Travoprost Vehiclehttps://ClinicalTrials.gov/show/NCT01298687
9680596805Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in PortugalCompletedNo Results AvailableAge-Related Macular Degeneration|Other Ocular Disease Such as: Diabetic Retinopathy, Glaucoma, Cataract, Etc.https://ClinicalTrials.gov/show/NCT01298674
9680696806Reliability, Sensitivity and Validity of the 6 Minute Step Test in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedHas ResultsChronic Obstructive Pulmonary DiseaseOther: Six-minute Step Testhttps://ClinicalTrials.gov/show/NCT01298661
9680796807Special Investigation in Patients With Crohn's Disease (All Patients Investigation)CompletedHas ResultsCrohn's Diseasehttps://ClinicalTrials.gov/show/NCT01298648
9680896808Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG)CompletedNo Results AvailableGlaucoma, Angle-Closure|CataractProcedure: combined phacotrabeculectomy|Procedure: trabeculectomyhttps://ClinicalTrials.gov/show/NCT01298635
9680996809The Imaging Genetic Study of the Core Family of Obsessive-compulsive Disorder (OCD) PatientRecruitingNo Results AvailableOCDhttps://ClinicalTrials.gov/show/NCT01298622
9681096810Occipital Nerve (C2) Stimulation in the Treatment of FibromyalgiaCompletedNo Results AvailableFibromyalgiaDevice: Occipital Stimulationhttps://ClinicalTrials.gov/show/NCT01298609

* Görseller ve İçerik tekif hakkına sahip olabilir